CMS certification 360085
Ohio State University State Health System
410 West 10th Avenue, Columbus, OH 43210
Ohio State University State Health System has a CMS overall rating of 3 out of 5 stars. 74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. Emergency patients spend a median of 5 h 17 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 2,595 completed surveys, 21% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | OH | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 380 visits sampled · US median for EDs of the same volume: 3 h 21 min | 5 h 17 min | 2 h 38 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 27 visits sampled | 9 h 6 min | 4 h 8 min | 4 h 17 min |
| Left before being seen Lower is better · 123,380 patients | 6% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 70 patients | 49% | 63% | 65% |
How Ohio State University State Health System compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Ohio State University State Health SystemThis hospital | 3/5 | 74% | 5 h 17 min | 5 better 1 worse |
| Mount Carmel East & WestSame city | 2/5 | 67% | 2 h 27 min | 1 better 4 worse |
| Riverside Methodist HospitalSame city | 4/5 | 76% | 3 h 50 min | 8 better |
| Grant Medical CenterSame city | 2/5 | 70% | 2 h 38 min | 3 better 3 worse |
| Doctors HospitalSame city | 4/5 | 68% | 2 h 58 min | 3 better |
| Diley Ridge Medical CenterSame county · Canal Winchester | Not rated | 85% | 1 h 49 min | — |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Columbus.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,180 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 159 cases | Too few cases | 12.8% | 11.9% |
| Heart failure 695 cases | Too few cases | 9.5% | 11.1% |
| Pneumonia 354 cases | Too few cases | 11.2% | 15.2% |
| Stroke 942 cases | Too few cases | 12.9% | 11.9% |
| COPD 134 cases | Too few cases | 6.9% | 8.6% |
| Heart bypass surgery (CABG) 144 cases | Too few cases | 2.3% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.96 likely 0.77 – 1.14 | 1 |
| After hip or knee replacement 120 cases | Too few cases | 3.9% | 4.1% |
| Deaths after a serious but treatable surgical complication 349 cases | No different | 192.6 per 1,000 likely 163.31 per 1,000 – 221.9 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 12,527 cases | No different | 0.28 per 1,000 likely 0 per 1,000 – 0.65 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 14,138 cases | No different | 0.14 per 1,000 likely 0 per 1,000 – 0.3 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 14,833 cases | No different | 0.29 per 1,000 likely 0.13 per 1,000 – 0.46 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,639 cases | No different | 2.2 per 1,000 likely 1.05 per 1,000 – 3.35 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 2,026 cases | No different | 2.57 per 1,000 likely 1.54 per 1,000 – 3.61 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 2,231 cases | No different | 9.88 per 1,000 likely 6.37 per 1,000 – 13.39 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 4,450 cases | No different | 3.43 per 1,000 likely 2.01 per 1,000 – 4.85 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 2,130 cases | No different | 5.82 per 1,000 likely 3.5 per 1,000 – 8.14 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,065 cases | No different | 2.39 per 1,000 likely 1.13 per 1,000 – 3.66 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,100 cases | No different | 0.99 per 1,000 likely 0.21 per 1,000 – 1.77 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.87 likely 0.62 – 1.18 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.6 likely 0.42 – 0.83 | 1 |
| Surgical site infections after colon surgery | No different | 1.13 likely 0.66 – 1.82 | 1 |
| Surgical site infections after abdominal hysterectomy | Worse | 3.33 likely 1.55 – 6.32 | 1 |
| MRSA bloodstream infections | No different | 1.09 likely 0.76 – 1.53 | 1 |
| C. diff intestinal infections | Better | 0.5 likely 0.39 – 0.63 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 302 cases | Too few cases | 13.5% | 14.4% |
| Readmitted after heart failure 1,369 cases | Too few cases | 19.4% | 21.3% |
| Readmitted after pneumonia 661 cases | Too few cases | 14.7% | 17.3% |
| Readmitted after COPD 361 cases | Too few cases | 20.1% | 20% |
| Readmitted after heart bypass surgery 157 cases | Too few cases | 13.5% | 11% |
| Readmitted after hip or knee replacement 116 cases | Too few cases | 6.7% | 5.8% |
| Days back in hospital after a heart attack 199 cases | Too few cases | -24.4 days per 100 | — |
| Days back in hospital after heart failure 862 cases | Too few cases | -5.6 days per 100 | — |
| Days back in hospital after pneumonia 398 cases | Too few cases | -9.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,554 cases | No different | 15.8 per 1,000 likely 12.4 per 1,000 – 20.2 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 54 cases | No different | 8.7 per 100 likely 6 per 100 – 12.5 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 54 cases | No different | 5.2 per 100 likely 3.3 per 100 – 7.9 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,241 cases | No different | 0.9 likely 0.8 – 1.1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
1,474 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 249 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 198 |
| Pharmacist | 182 |
| Nurse Anesthetist, Certified Registered | 150 |
| Hospitalist | 112 |
| Emergency Medicine | 106 |
| Nurse Practitioner | 71 |
| Anatomic Pathology & Clinical Pathology | 54 |
| Anesthesiologist Assistant | 50 |
| Physician Assistant | 50 |
| Gastroenterology | 35 |
| Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist | 35 |
| Dietitian, Registered | 33 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.5M
- 2020 $1.6M
- 2021 $6.3M
- 2022 $4.5M
- 2023 $3.4M
- 2024 $6.9M
- 2025 $6.4M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $311,028 | 18 |
| Education | $252,082 | 25 |
| Debt forgiveness | $45,927 | 10 |
| Consulting fees | $30,592 | 7 |
| Space rental and facility fees | $10,500 | 3 |
| Gifts | $6,808 | 1 |
| Speaking, teaching and other services | $2,875 | 6 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2.6M | 4 |
| Abbvie INC. | $2M | 14 |
| Dexcom, Inc. | $447,474 | 7 |
| Intuitive Surgical, INC. | $349,490 | 31 |
| Takeda Pharmaceuticals U.S.A., Inc. | $231,748 | 4 |
| Karyopharm Therapeutics Inc. | $129,674 | 58 |
| Ipsen Biopharmaceuticals, Inc | $124,650 | 1 |
| Verastem, Inc. | $105,092 | 5 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Prospective Randomized Phase 2 study of Acalabrutinib and Obinutuzumab or Venetoclax in previously untreated or minimally treated CLL AstraZeneca Pharmaceuticals LP | $1.5M |
| A Phase II Study of the Bruton s Tyrosine Kinase (Btk) Inhibitor, PCI-32765, in Relapsed and Refractory Patients with Chronic Lymphocytic Lymphoma (C… ABBVIE INC. · NCT01589302 | $1M |
| Prospective Phase 2 study of the effect of Acalabrutinib on myocardium on Ibrutinib exposed patients with CLL AstraZeneca Pharmaceuticals LP | $837,103 |
| Phase Ib/II Trial of Epcoritamab plus Ibrutinib in Patients with Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma ABBVIE INC. | $493,468 |
| Implementation of real-time continuous glucose monitoring in the hospital setting Dexcom, Inc. | $291,534 |
| A Phase I, Dose-escalation Trial of Rituximab and Bendamustine in Combination with Brutons Tyrosine Kinase Inhibitor, PCI-32765, in Patients with Rel… ABBVIE INC. · NCT01479842 | $278,180 |
| A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin s Lymphoma ABBVIE INC. · NCT02940301 | $193,517 |
| A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with High-Risk Myelofibrosis Karyopharm Therapeutics Inc. | $129,674 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Ohio State University State Health System
Is Ohio State University State Health System a good hospital?
Ohio State University State Health System has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Ohio State University State Health System?
74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 2,595 completed HCAHPS surveys.
How long is the wait in the Ohio State University State Health System emergency room?
Emergency patients spend a median of 5 h 17 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 6% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Ohio State University State Health System receive money from drug and device companies?
Drug and device makers reported $6.4M in payments to Ohio State University State Health System for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.